<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32447552</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>267</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>SPG7 mutations in amyotrophic lateral sclerosis: a genetic link to hereditary spastic paraplegia.</ArticleTitle><Pagination><StartPage>2732</StartPage><EndPage>2743</EndPage><MedlinePgn>2732-2743</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-020-09861-w</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) and hereditary spastic paraplegia (HSP) are motor neuron diseases sharing clinical, pathological, and genetic similarities. While biallelic SPG7 mutations are known to cause recessively inherited HSP, heterozygous SPG7 mutations have repeatedly been identified in HSP and recently also in ALS cases. However, the frequency and clinical impact of rare SPG7 variants have not been studied in a larger ALS cohort. Here, whole-exome (WES) or targeted SPG7 sequencing was done in a cohort of 214 European ALS patients. The consequences of a splice site variant were analyzed on the mRNA level. The resulting protein alterations were visualized in a crystal structure model. All patients were subjected to clinical, electrophysiological, and neuroradiological characterization. In 9 of 214 (4.2%) ALS cases, we identified five different rare heterozygous SPG7 variants, all of which were previously reported in patients with HSP or ALS. All detected SPG7 variants affect the AAA+&#x2009;domain of the encoded mitochondrial metalloprotease paraplegin and impair its stability or function according to predictions from mRNA analysis or crystal structure modeling. ALS patients with SPG7 mutations more frequently presented with cerebellar symptoms, flail arm or leg syndrome compared to those without SPG7 mutations, and showed a partial clinical overlap with HSP. Brain MRI findings in SPG7 mutation carriers included cerebellar atrophy and patterns suggestive of frontotemporal dementia. Collectively, our findings suggest that SPG7 acts as a genetic risk factor for ALS. ALS patients carrying SPG7 mutations present with distinct features overlapping with HSP, particularly regarding cerebellar findings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Osmanovic</LastName><ForeName>Alma</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, Carl-Neuberg-Stra&#xdf;e 1, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Widjaja</LastName><ForeName>Maylin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, Carl-Neuberg-Stra&#xdf;e 1, 30625, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>F&#xf6;rster</LastName><ForeName>Alisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, Carl-Neuberg-Stra&#xdf;e 1, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weder</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Biophysical Chemistry, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wattjes</LastName><ForeName>Mike P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Inken</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarikidi</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Auber</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, Carl-Neuberg-Stra&#xdf;e 1, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raab</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christians</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, Carl-Neuberg-Stra&#xdf;e 1, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preller</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Biophysical Chemistry, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petri</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Ruthild G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, Hannover Medical School, Carl-Neuberg-Stra&#xdf;e 1, 30625, Hannover, Germany. Weber.Ruthild@mh-hannover.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KlinStrucMed program of Hannover Medical School</GrantID><Agency>Else Kr&#xf6;ner-Fresenius-Stiftung</Agency><Country/></Grant><Grant><GrantID>PRACTIS - Clinician Scientist Program of Hannover Medical School, grant no. ME3696/3-1</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant><Grant><GrantID>KO5614/2-1</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.24.-</RegistryNumber><NameOfSubstance UI="D008666">Metalloendopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.-</RegistryNumber><NameOfSubstance UI="C112889">SPG7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D000074183">ATPases Associated with Diverse Cellular Activities</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000074183" MajorTopicYN="N">ATPases Associated with Diverse Cellular Activities</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008666" MajorTopicYN="N">Metalloendopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015419" MajorTopicYN="Y">Spastic Paraplegia, Hereditary</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Hereditary spastic paraplegia</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">SPG7</Keyword><Keyword MajorTopicYN="N">Whole-exome sequencing</Keyword></KeywordList><CoiStatement>AO received honoraria from Biogen; MPW received honoraria from Bayer, Biogen, Biologix, Celgene, Genilac, Imcyse, IXICO, Medison, Merck-Serono, Novartis, Roche, Sanofi-Genzyme, Spinger Healthcare, and Teva; PR received honoraria from Biogen and IXICO; SP received honoraria from Biogen, Cytokinetics, Inc., Desitin Pharma, Novartis, Roche, and Teva. MW, AF, JW, IL, AS, BA, AC, MP, and RGW report no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32447552</ArticleId><ArticleId IdType="pmc">PMC7419373</ArticleId><ArticleId IdType="doi">10.1007/s00415-020-09861-w</ArticleId><ArticleId IdType="pii">10.1007/s00415-020-09861-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Patten SA, Armstrong GA, Lissouba A, Kabashi E, Parker JA, Drapeau P. Fishing for causes and cures of motor neuron disorders. Dis Model Mech. 2014;7(7):799&#x2013;809. doi: 10.1242/dmm.015719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.015719</ArticleId><ArticleId IdType="pmc">PMC4073270</ArticleId><ArticleId IdType="pubmed">24973750</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013;14(4):248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza PVS, de Rezende Pinto WBV, de Rezende Batistella GN, Bortholin T, Oliveira ASB. Hereditary spastic paraplegia: clinical and genetic hallmarks. Cerebellum. 2017;16(2):525&#x2013;551. doi: 10.1007/s12311-016-0803-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-016-0803-z</ArticleId><ArticleId IdType="pubmed">27271711</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bot ST, Schelhaas HJ, Kamsteeg EJ, van de Warrenburg BP. Hereditary spastic paraplegia caused by a mutation in the VCP gene. Brain. 2012;135(Pt 12):e223. doi: 10.1093/brain/aws201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws201</ArticleId><ArticleId IdType="pubmed">22991237</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H, Zhou S, Noreau A, Sabbagh M, Belzil V, Dionne-Laporte A, Tranchant C, Dion P, Rouleau GA. Exome sequencing reveals SPG11 mutations causing juvenile ALS. Neurobiol Aging. 2012;33(4):839.e835&#x2013;839. doi: 10.1016/j.neurobiolaging.2011.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.11.012</ArticleId><ArticleId IdType="pubmed">22154821</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, Yilmaz R, Muller K, Grehl T, Petri S, Meyer T, Grosskreutz J, Weydt P, Ruf W, Neuwirth C, Weber M, Pinto S, Claeys KG, Schrank B, Jordan B, Knehr A, Gunther K, Hubers A, Zeller D, Kubisch C, Jablonka S, Sendtner M, Klopstock T, de Carvalho M, Sperfeld A, Borck G, Volk AE, Dorst J, Weis J, Otto M, Schuster J, Del Tredici K, Braak H, Danzer KM, Freischmidt A, Meitinger T, Strom TM, Ludolph AC, Andersen PM, Weishaupt JH, German ALSnMNDNET Hot-spot KIF5A mutations cause familial ALS. Brain. 2018;141(3):688&#x2013;697. doi: 10.1093/brain/awx370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx370</ArticleId><ArticleId IdType="pmc">PMC5837483</ArticleId><ArticleId IdType="pubmed">29342275</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Calvo A, Moglia C, Mazzini L, Mora G, Group Ps Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82(7):740&#x2013;746. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Labra J, Menon P, Byth K, Morrison S, Vucic S. Rate of disease progression: a prognostic biomarker in ALS. J Neurol Neurosurg Psychiatry. 2016;87(6):628&#x2013;632. doi: 10.1136/jnnp-2015-310998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310998</ArticleId><ArticleId IdType="pubmed">26152368</ArticleId></ArticleIdList></Reference><Reference><Citation>Loose M, Burkhardt C, Aho-Ozhan H, Keller J, Abdulla S, Bohm S, Kollewe K, Uttner I, Abrahams S, Petri S, Weber M, Ludolph AC, Lule D. Age and education-matched cut-off scores for the revised German/Swiss&#x2013;German version of ECAS. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(5&#x2013;6):374&#x2013;376. doi: 10.3109/21678421.2016.1162814.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1162814</ArticleId><ArticleId IdType="pubmed">27027323</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55(11):1621&#x2013;1626. doi: 10.1212/wnl.55.11.1621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.55.11.1621</ArticleId><ArticleId IdType="pubmed">11113214</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanovic A, Rangnau I, Kosfeld A, Abdulla S, Janssen C, Auber B, Raab P, Preller M, Petri S, Weber RG. FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study. Eur J Hum Genet. 2017;25(3):324&#x2013;331. doi: 10.1038/ejhg.2016.186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2016.186</ArticleId><ArticleId IdType="pmc">PMC5315518</ArticleId><ArticleId IdType="pubmed">28051077</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ferrero E, Coto E, Beetz C, Gamez J, Corao AI, Diaz M, Esteban J, del Castillo E, Moris G, Infante J, Menendez M, Pascual-Pascual SI, Lopez de Munain A, Garcia-Barcina MJ, Alvarez V, Genetics of Spastic Paraplegia study g SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Clin Genet. 2013;83(3):257&#x2013;262. doi: 10.1111/j.1399-0004.2012.01896.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2012.01896.x</ArticleId><ArticleId IdType="pubmed">22571692</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405&#x2013;424. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlberg T, van den Berg S, Hammarstrom M, Sagemark J, Johansson I, Holmberg-Schiavone L, Schuler H. Crystal structure of the ATPase domain of the human AAA+ protein paraplegin/SPG7. PLoS ONE. 2009;4(10):e6975. doi: 10.1371/journal.pone.0006975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0006975</ArticleId><ArticleId IdType="pmc">PMC2734466</ArticleId><ArticleId IdType="pubmed">19841671</ArticleId></ArticleIdList></Reference><Reference><Citation>MacroModel. Schr&#xf6;dinger Release 2018-1 (2018) Schr&#xf6;dinger, LLC, New York</Citation></Reference><Reference><Citation>Harder E, Damm W, Maple J, Wu C, Reboul M, Xiang JY, Wang L, Lupyan D, Dahlgren MK, Knight JL, Kaus JW, Cerutti DS, Krilov G, Jorgensen WL, Abel R, Friesner RA. OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput. 2016;12(1):281&#x2013;296. doi: 10.1021/acs.jctc.5b00864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.5b00864</ArticleId><ArticleId IdType="pubmed">26584231</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Pagani M, Agosta F, Calvo A, Cistaro A, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol. 2014;13(12):1228&#x2013;1240. doi: 10.1016/S1474-4422(14)70167-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70167-X</ArticleId><ArticleId IdType="pubmed">25453462</ArticleId></ArticleIdList></Reference><Reference><Citation>Warnecke T, Duning T, Schirmacher A, Mohammadi S, Schwindt W, Lohmann H, Dziewas R, Deppe M, Ringelstein EB, Young P. A novel splice site mutation in the SPG7 gene causing widespread fiber damage in homozygous and heterozygous subjects. Mov Disord. 2010;25(4):413&#x2013;420. doi: 10.1002/mds.22949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22949</ArticleId><ArticleId IdType="pubmed">20108356</ArticleId></ArticleIdList></Reference><Reference><Citation>Klebe S, Depienne C, Gerber S, Challe G, Anheim M, Charles P, Fedirko E, Lejeune E, Cottineau J, Brusco A, Dollfus H, Chinnery PF, Mancini C, Ferrer X, Sole G, Destee A, Mayer JM, Fontaine B, de Seze J, Clanet M, Ollagnon E, Busson P, Cazeneuve C, Stevanin G, Kaplan J, Rozet JM, Brice A, Durr A. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. Brain. 2012;135(Pt 10):2980&#x2013;2993. doi: 10.1093/brain/aws240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws240</ArticleId><ArticleId IdType="pmc">PMC3470714</ArticleId><ArticleId IdType="pubmed">23065789</ArticleId></ArticleIdList></Reference><Reference><Citation>Blinkov SM, Glezer II. Das zentralnervensystem in zahlen und tabellen. Jena: Fischer; 1968.</Citation></Reference><Reference><Citation>Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, Gibbs JR, Brunetti M, Gronka S, Wuu J, Ding J, McCluskey L, Martinez-Lage M, Falcone D, Hernandez DG, Arepalli S, Chong S, Schymick JC, Rothstein J, Landi F, Wang YD, Calvo A, Mora G, Sabatelli M, Monsurro MR, Battistini S, Salvi F, Spataro R, Sola P, Borghero G, Consortium I. Galassi G, Scholz SW, Taylor JP, Restagno G, Chio A, Traynor BJ. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68(5):857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, Durr A, Fontaine B, Ballabio A. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell. 1998;93(6):973&#x2013;983. doi: 10.1016/s0092-8674(00)81203-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)81203-9</ArticleId><ArticleId IdType="pubmed">9635427</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer G, Pyle A, Griffin H, Miller J, Wilson V, Turnbull L, Fawcett K, Sims D, Eglon G, Hadjivassiliou M, Horvath R, Nemeth A, Chinnery PF. SPG7 mutations are a common cause of undiagnosed ataxia. Neurology. 2015;84(11):1174&#x2013;1176. doi: 10.1212/WNL.0000000000001369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001369</ArticleId><ArticleId IdType="pmc">PMC4371411</ArticleId><ArticleId IdType="pubmed">25681447</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugman F, Scheffer H, Wokke JH, Nillesen WM, de Visser M, Aronica E, Veldink JH, van den Berg LH. Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. Neurology. 2008;71(19):1500&#x2013;1505. doi: 10.1212/01.wnl.0000319700.11606.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000319700.11606.21</ArticleId><ArticleId IdType="pubmed">18799786</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer G, Gorman GS, Griffin H, Kurzawa-Akanbi M, Blakely EL, Wilson I, Sitarz K, Moore D, Murphy JL, Alston CL, Pyle A, Coxhead J, Payne B, Gorrie GH, Longman C, Hadjivassiliou M, McConville J, Dick D, Imam I, Hilton D, Norwood F, Baker MR, Jaiser SR, Yu-Wai-Man P, Farrell M, McCarthy A, Lynch T, McFarland R, Schaefer AM, Turnbull DM, Horvath R, Taylor RW, Chinnery PF. Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance. Brain. 2014;137(Pt 5):1323&#x2013;1336. doi: 10.1093/brain/awu060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu060</ArticleId><ArticleId IdType="pmc">PMC3999722</ArticleId><ArticleId IdType="pubmed">24727571</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger S, Battke F, Sprecher A, Munz M, Synofzik M, Schols L, Gasser T, Grehl T, Prudlo J, Biskup S. Rare variants in neurodegeneration associated genes revealed by targeted panel sequencing in a German ALS Cohort. Front Mol Neurosci. 2016;9:92. doi: 10.3389/fnmol.2016.00092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00092</ArticleId><ArticleId IdType="pmc">PMC5061735</ArticleId><ArticleId IdType="pubmed">27790088</ArticleId></ArticleIdList></Reference><Reference><Citation>Garton FC, Benyamin B, Zhao Q, Liu Z, Gratten J, Henders AK, Zhang ZH, Edson J, Furlong S, Morgan S, Heggie S, Thorpe K, Pfluger C, Mather KA, Sachdev PS, McRae AF, Robinson MR, Shah S, Visscher PM, Mangelsdorf M, Henderson RD, Wray NR, McCombe PA. Whole exome sequencing and DNA methylation analysis in a clinical amyotrophic lateral sclerosis cohort. Mol Genet Genomic Med. 2017;5(4):418&#x2013;428. doi: 10.1002/mgg3.302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mgg3.302</ArticleId><ArticleId IdType="pmc">PMC5511806</ArticleId><ArticleId IdType="pubmed">28717666</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonn F, Pantakani K, Shoukier M, Langer T, Mannan AU. Functional evaluation of paraplegin mutations by a yeast complementation assay. Hum Mutat. 2010;31(5):617&#x2013;621. doi: 10.1002/humu.21226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21226</ArticleId><ArticleId IdType="pubmed">20186691</ArticleId></ArticleIdList></Reference><Reference><Citation>Franca MC, Jr, D'Abreu A, Maurer-Morelli CV, Seccolin R, Appenzeller S, Alessio A, Damasceno BP, Nucci A, Cendes F, Lopes-Cendes I. Prospective neuroimaging study in hereditary spastic paraplegia with thin corpus callosum. Mov Disord. 2007;22(11):1556&#x2013;1562. doi: 10.1002/mds.21480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.21480</ArticleId><ArticleId IdType="pubmed">17516453</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gassen KL, van der Heijden CD, de Bot ST, den Dunnen WF, van den Berg LH, Verschuuren-Bemelmans CC, Kremer HP, Veldink JH, Kamsteeg EJ, Scheffer H, van de Warrenburg BP. Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort. Brain. 2012;135(Pt 10):2994&#x2013;3004. doi: 10.1093/brain/aws224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws224</ArticleId><ArticleId IdType="pubmed">22964162</ArticleId></ArticleIdList></Reference><Reference><Citation>Warnecke T, Duning T, Schwan A, Lohmann H, Epplen JT, Young P. A novel form of autosomal recessive hereditary spastic paraplegia caused by a new SPG7 mutation. Neurology. 2007;69(4):368&#x2013;375. doi: 10.1212/01.wnl.0000266667.91074.fe.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000266667.91074.fe</ArticleId><ArticleId IdType="pubmed">17646629</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewamadduma CA, Hoggard N, O'Malley R, Robinson MK, Beauchamp NJ, Segamogaite R, Martindale J, Rodgers T, Rao G, Sarrigiannis P, Shanmugarajah P, Zis P, Sharrack B, McDermott CJ, Shaw PJ, Hadjivassiliou M. Novel genotype-phenotype and MRI correlations in a large cohort of patients with SPG7 mutations. Neurol Genet. 2018;4(6):e279. doi: 10.1212/NXG.0000000000000279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000279</ArticleId><ArticleId IdType="pmc">PMC6244025</ArticleId><ArticleId IdType="pubmed">30533525</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, van Es MA, Hennekam EA, Dooijes D, van Rheenen W, Medic J, Bourque PR, Schelhaas HJ, van der Kooi AJ, de Visser M, de Bakker PI, Veldink JH, van den Berg LH. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21(17):3776&#x2013;3784. doi: 10.1093/hmg/dds199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds199</ArticleId><ArticleId IdType="pubmed">22645277</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9(11):617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Atorino L, Silvestri L, Koppen M, Cassina L, Ballabio A, Marconi R, Langer T, Casari G. Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol. 2003;163(4):777&#x2013;787. doi: 10.1083/jcb.200304112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200304112</ArticleId><ArticleId IdType="pmc">PMC2173682</ArticleId><ArticleId IdType="pubmed">14623864</ArticleId></ArticleIdList></Reference><Reference><Citation>Pareek G, Thomas RE, Pallanck LJ. Loss of the Drosophila m-AAA mitochondrial protease paraplegin results in mitochondrial dysfunction, shortened lifespan, and neuronal and muscular degeneration. Cell Death Dis. 2018;9(3):304. doi: 10.1038/s41419-018-0365-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0365-8</ArticleId><ArticleId IdType="pmc">PMC5833341</ArticleId><ArticleId IdType="pubmed">29467464</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogel BL, Lee H, Deignan JL, Strom SP, Kantarci S, Wang X, Quintero-Rivera F, Vilain E, Grody WW, Perlman S, Geschwind DH, Nelson SF. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol. 2014;71(10):1237&#x2013;1246. doi: 10.1001/jamaneurol.2014.1944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1944</ArticleId><ArticleId IdType="pmc">PMC4324730</ArticleId><ArticleId IdType="pubmed">25133958</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J, Raphael AR, Daneshjou R, Gitler AD. Targeted exon capture and sequencing in sporadic amyotrophic lateral sclerosis. PLoS Genet. 2014;10(10):e1004704. doi: 10.1371/journal.pgen.1004704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004704</ArticleId><ArticleId IdType="pmc">PMC4191946</ArticleId><ArticleId IdType="pubmed">25299611</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnoldi A, Tonelli A, Crippa F, Villani G, Pacelli C, Sironi M, Pozzoli U, D'Angelo MG, Meola G, Martinuzzi A, Crimella C, Redaelli F, Panzeri C, Renieri A, Comi GP, Turconi AC, Bresolin N, Bassi MT. A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia. Hum Mutat. 2008;29(4):522&#x2013;531. doi: 10.1002/humu.20682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20682</ArticleId><ArticleId IdType="pubmed">18200586</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott CJ, Dayaratne RK, Tomkins J, Lusher ME, Lindsey JC, Johnson MA, Casari G, Turnbull DM, Bushby K, Shaw PJ. Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. Neurology. 2001;56(4):467&#x2013;471. doi: 10.1212/wnl.56.4.467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.56.4.467</ArticleId><ArticleId IdType="pubmed">11222789</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>